This webinar will be hosted readily available and live on-demandWednesday, November 29, 2023 12:00 PM Eastern Time Cutaneous melanoma is one of the deadliest kinds of skin cancer in part due to its intrinsic cellular plasticity and heterogeneity. These attributes have made it challenging to comprehend and effectively treat cancer malignancy. In spite of advances in cancer malignancy phenotyping, measuring morphological differences in between cells stays a hurdle.In this webinar brought to you by Deepcell, Evelyn Lattmann will present a synthetic intelligence (AI)- based microscopy approach that enabled her to morphologically categorize cancer malignancy cells without fluorescent labels.Topics to be covered Introduction to taking a look at cell morphology utilizing a label-free, AI-driven cell analysis platformClassifying patient-derived cancer malignancy cells into melanocytic and mesenchymal phenotypes through morpholomicsEvelyn Lattmann, PhDScientist, Translational Cancer ResearchUniversity Hospital ZurichUniversity of ZurichSponsored by